当前位置: X-MOL 学术Curr. Pain Headache Rep. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Acupuncture Versus Oral Medications for Acute/Subacute Non-Specific Low Back Pain: A Systematic Review and Meta-Analysis
Current Pain and Headache Reports ( IF 3.7 ) Pub Date : 2024-01-08 , DOI: 10.1007/s11916-023-01201-7
Huize Lin , Xiang Wang , Yixuan Feng , Xiaoxu Liu , Lanping Liu , Kexin Zhu , Jianghong Shen , Pingping Zhang , Jinna Yu , Tao Yang

Purpose of Review

Pharmacologic intervention do not always achieve benefits in the treatment of acute/subacute non-specific low back pain (NSLBP). We assessed efficacy and safety of acupuncture for acute/subacute NSLBP as alternative treatment.

Recent Findings

We searched PubMed, Web of Science, Embase, Cochrane Library, Scopus, Epistemonikos, CNKI, Wan Fang Database, VIP database, CBMLD, CSTJ, clinical trials, EUCTR, World WHO ICTRP, and ChiCTR for randomized controlled trials, cross-over studies, and cohort studies of NSLBP treated by acupuncture versus oral medication from inception to 23th April 2022. A total of 6 784 records were identified, and 14 studies were included 1 263 participants in this review. The results of the meta-analysis indicated that acupuncture therapy was slightly more effective than oral medication in improving pain (P < 0.00001, I2 = 92%, MD = −1.17, 95% CI [−1.61, −0.72]). According to the results of the meta-analysis, acupuncture therapy exhibited a significant advantage over oral medication with a substantial effect (P < 0.00001, I2 = 90%, SMD = −1.42, 95% CI [−2.22, −0.62]). Based on the results of the meta-analysis, acupuncture therapy was associated with a 12% improvement rate compared to oral medication in patients with acute/subacute NSLBP (P < 0.0001, I2 = 54%, RR = 1.11, 95% CI [1.05, 1.18]).

Summary

Acupuncture is more effective and safer than oral medication in treating acute/subacute NSLBP. This systematic review is poised to offer valuable guidance to clinicians treating acute/subacute NSLBP and potentially benefit the afflicted patients.

Registration

This review was registered in PROSPERO (http://www.crd.york.ac.uk/prospero) with registration number CRD42021278346.



中文翻译:

针灸与口服药物治疗急性/亚急性非特异性腰痛:系统评价和荟萃分析

审查目的

药物干预在治疗急性/亚急性非特异性腰痛 (NSLBP) 方面并不总能带来益处。我们评估了针灸作为替代疗法治疗急性/亚急性 NSLBP 的疗效和安全性。

最近的发现

我们检索了 PubMed、Web of Science、Embase、Cochrane Library、Scopus、Epistemonikos、CNKI、万方数据库、VIP 数据库、CBMLD、CSTJ、临床试验、EUCTR、World WHO ICTRP 和 ChiCTR 的随机对照试验、交叉研究,以及从开始到 2022 年 4 月 23 日期间针灸与口服药物治疗 NSLBP 的队列研究。本次综述共确定了 6 784 条记录,14 项研究纳入了 1 263 名参与者。荟萃分析结果表明,针灸疗法在改善疼痛方面比口服药物稍有效(P  < 0.00001,I 2  = 92%,MD = -1.17,95% CI [-1.61,-0.72])。根据荟萃分析的结果,针灸疗法比口服药物具有显着优势,且疗效显着(P  < 0.00001,I 2  = 90%,SMD = -1.42,95% CI [-2.22,-0.62]) 。根据荟萃分析的结果,与口服药物相比,针灸治疗急性/亚急性 NSLBP 患者的改善率达 12%(P  < 0.0001,I 2  = 54%,RR = 1.11,95% CI [ 1.05、1.18])。

概括

针灸治疗急性/亚急性 NSLBP 比口服药物更有效、更安全。这项系统评价将为治疗急性/亚急性 NSLBP 的临床医生提供有价值的指导,并可能使受影响的患者受益。

登记

该评论已在 PROSPERO (http://www.crd.york.ac.uk/prospero) 上注册,注册号为 CRD42021278346。

更新日期:2024-01-08
down
wechat
bug